Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the management of type 2 diabetes (T2D). However, recently published data from retrospective cohort studies suggest that chronic exposure to GLP-1RAs in T2D may increase the risk of papillary and medullary thyroid cancer....

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Giuseppe Lisco, Anna De Tullio, Olga Disoteo, Giuseppina Piazzolla, Edoardo Guastamacchia, Carlo Sabbà, Vincenzo De Geronimo, Enrico Papini, Vincenzo Triggiani
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Bioscientifica 2023-10-01
Serie:	Endocrine Connections
Ämnen:	dipeptidyl peptidase iv glucagon-like peptide 1 receptor agonist incretin system medullary thyroid cancer papillary thyroid cancer
Länkar:	https://ec.bioscientifica.com/view/journals/ec/12/11/EC-23-0257.xml
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!